The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Walder Wyss Ltd

SEEFELDSTRASSE 123, PO BOX 1236, 8034 ZURICH, SWITZERLAND
Tel:
Work +41 58 658 58 58
Fax:
Fax +41 58 658 59 59
Email:
Web:
www.walderwyss.com

The firm

Walder Wyss is one of the most successful and fastest growing Swiss commercial law firms. The firm specialises in corporate and commercial law, banking and finance, intellectual property and competition law, dispute resolution and tax law. Its clients include national and international companies, publicly held corporations and family businesses as well as public law institutions and private clients.

Growth and a close relationship to its clients are the factors that determine the firm’s success. Walder Wyss was established in Zurich in 1972 and has since grown continuously. With offices in Zurich, Geneva, Basel, Berne, Lausanne and Lugano, it provides its clients with seamless one-stop-shop, personalised and high-quality services in all language regions of Switzerland.

Its strong national and international network of correspondents and partners from a broad range of disciplines are selected according to the highest standards of professional competence.

Areas of practice

Banking, finance and insurance: Walder Wyss handles domestic and international banking, securitisations, infrastructure and project finance, domestic and cross-border leasing, and structured financial instruments, as well as over-the-counter and exchange-traded derivatives. Walder Wyss advises on all aspects of Swiss securities laws and regulations.

IT, telecommunications and multimedia: Walder Wyss focuses on the interlinked and converging areas of information technology, internet, multimedia, as well as media and telecommunications law. It advises on software protection, licensing issues, systems integration contracts, and data processing contracts.

Intellectual property: the firm has a wide range of experience in protecting intellectual property rights, as well as exploiting such rights by way of licensing, franchising and merchandising.

Corporate and commercial: Walder Wyss advises on and assists in the incorporation and organisation of business activities in Switzerland, including the establishment of corporations, partnerships, limited partnerships, joint ventures and non-profit organisations.

M&A, restructuring, joint ventures, IPOs and private equity: Walder Wyss handles the structuring and implementation of corporate mergers, acquisitions and divestitures, outsourcings, shareholder agreements, takeovers, demergers, capital restructurings, repurchases of shares, management buyouts, joint ventures, reorganisations, cross-border business arrangements and other direct investment transactions. Walder Wyss advises on seed, early stage and growth financing.

Litigation, arbitration and ADR: Walder Wyss is renowned for its international arbitration and litigation practice. This is reflected both by a high number of arbitration cases, both with respect to party representation and arbitrator appointments, and a well-established commercial court practice leading to an important number of pending cases before the Zurich Commercial Court and other relevant courts throughout Switzerland.

Tax: Walder Wyss’ tax specialists advise on private and public M&A, capital market transactions, IPOs, real estate, structured finance, tax-optimised financial products and investment funds.

Competition/antitrust: Walder Wyss is proficient in all aspects of the regulation of competition. The competition team regularly handles complex merger filings in Switzerland and co-ordinates them with filings in other jurisdictions. The team is routinely involved in questions of market dominance and the design of agreements that do not violate competition law.

Private clients: Walder Wyss advises high-net-worth individuals regarding domestic and international estate planning and provides tailor-made succession solutions. Its services include drafting of wills, pre- and post-nuptial agreements, particularly matrimonial property agreements, and inheritance contracts, as well as any related contractual arrangements, all of which are drawn up in close collaboration with Walder Wyss’ experienced notaries. The firm supports relocations and taking up residence in Switzerland and the planning and setting up of appropriate structures.

  • Contacts
  • J Bürgi (management board)
  • L Defferrard (management board)
  • F Gunz Niedermann (management board)
  • H R Trüeb (management board)
  • Reto Vonzun (management board)
  • Other offices
  • Basel
  • Berne
  • Geneva
  • Lausanne
  • Lugano
  • Number of lawyers: 200
  • Languages
  • English
  • French
  • German
  • Spanish
  • Greek
  • Dutch
  • Hebrew
  • Hindi
  • Hungarian
  • Italian
  • Polish
  • Russian
  • Swedish
  • Farsi
  • Croatian
  • Serbian
  • Persian
  • Rhaeto-Romanic

Above material supplied by Walder Wyss Ltd.

Legal Developments by:
Walder Wyss

  • 17 February 2017: Auris Medical's Public Equity Offering

    Auris Medical Holding AG (NASDAQ: EARS) issued and priced its public offering of 10,000,000 common shares and 10,000,000 warrants, each warrant entitling its holder to purchase 0.70 of a common share.  The common shares and warrants are being sold in units comprised of one common share and one warrant at the public offering price of USD 1.00 per unit. The warrants will be immediately exercisable at a price of USD 1.20 per common share and are exercisable for five years. In connection with the offering, the Company has granted the underwriter a 30-day option to purchase up to 1,500,000 additional common shares and/or 1,500,000 additional warrants at the public offering price less underwriting discounts. The offering is expected to close on or about February 21, 2017, subject to customary closing conditions. Roth Capital Partners is acting as sole book-running manager in the offering. Maxim Group LLC is acting as a financial advisor in the offering.
    - Walder Wyss Ltd

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • Bär & Karrer Continues to Grow Finance and Sports Practice with Two New Partners

    Bär & Karrer is pleased to announce that it further strengthens its Financing and Sports practices with new partners Lukas Roesler and Dr. Jan Kleiner, both of whom have worked with the firm previously.
  • Bär & Karrer Advises Novartis and Alcon on the Spin-off of Alcon

    Today, Novartis AG completed the spin-off of the Alcon eye care devices business, and Alcon Inc. debuted as independent publicly traded company. The Alcon shares were successfully listed on the SIX Swiss Exchange Ltd. and the New York Stock Exchange. They are also included in the Swiss Market Index (SMI), which comprises the 20 largest Swiss listed stocks.
  • Bär & Karrer Advises Primeo Energie and CSA Energie-Infrastructure Schweiz in Aquisition from Elét

    Primeo Energie, EOS Holding SA (EOS) and Électricité de France (EDF) have entered into a share purchase agreement relating to the purchase by Primeo Energie and EOS of the 25% interest held by EDF in Alpiq Holding SA. The purchase by Primeo Eergie and EOS will be financed through mandatory exchangeable loan agreements made by CSA Energie-Infrastruktur Schweiz (CSA) as lender, the biggest investment pool for Swiss energy infrastructure with 135 Swiss pension funds acting as investors. At maturity the mandatory exchangeable loan agreements will be converted into shares in Alpiq. Primeo Energie and EOS thereby pave the way for a Swiss shareholder structure of Alpiq.
  • Bär & Karrer Awarded Most Innovative Swiss Law Firm of the Year at the IFLR Europe Awards

    Bär & Karrer was awarded „Most innovative law firm of the year - Switzerland", the national award for Switzerland given in the IFLR European Awards. The most innovative law firm of the year award recognizes Bär & Karrer as the Swiss law firm with the best track record in 2018 giving advice on the most innovative cross-border deals covering all award practice areas. It is already the third prize of this kind in period of six years awarded to Bär & Karrer.
  • Bär & Karrer Advises DSV on Public Exchange Offer for Panalpina

    On 1 April 2019, DSV A/S, Hedehusene, Denmark and Panalpina Welttransport (Holding) AG, Zurich, Switzerland, have entered into an agreement on the terms and conditions of a combination by way of a public exchange offer by DSV for all publicly held registered shares of Panalpina for approximately CHF 4.6 billion. The board of directors of Panalpina has resolved to support the public exchange offer by DSV and to recommend the acceptance of DSV's public exchange offer to its shareholders.
  • Bär & Karrer Advises Lonza on the Entering into a Strategic Joint Venture with Chr. Hansen for Deve

    On 2 April 2019, Lonza, a leading pharma contract manufacturing company, and Chr. Hansen, a leading global bioscience company, announced that they have signed an agreement to establish a 50/50 joint venture to pioneer the live biotherapeutic products (LBPs) industry and position themselves as the leading contract development and manufacturing partner (CDMO) for biotech and pharma customers. The joint venture brings together best-in-class, complementary capabilities and will be the first CDMO globally to provide a full supply chain that offers manufacturing of bacteria strains for therapeutic use. The joint venture will be a 50/50 controlled legal entity that will operate from its headquarters in Basel (CH) and have production facilities in Denmark and Switzerland. A phased investment of approximately EUR 90 million will be deployed over three years to build cGMP-compliant pharma production capabilities. The joint venture will upgrade existing facilities in Hørsholm (DK) and equip new facilities in Basel (CH) to serve pre-clinical to phase II projects. Further facilities for phase III and commercial manufacturing will be developed as the pipeline matures. The joint venture is expected to be largely self-funding after the production set-up has been established.
  • Bär & Karrer Advises Computacenter in the Acquisition of PathWorks

    Computacenter Group, a leading European IT service provider listed on the London Stock Exchange, acquired PathWorks, a well-established hardware reseller in the Swiss market.
  • Bär & Karrer Advises Addtech in the Acquisition of a Majority in Omni Ray

    Addtech Group, a leading Swedish publicly listed technology trading group, acquired a majority stake in Omni Ray AG, a well-established Swiss trading company and service provider for automation solutions, mainly focused on industrial applications, infrastructure, transportation and medical industry. By this transaction, Addtech aims at strengthening its position in the European automation market.
  • Bär & Karrer Partner Paolo Bottini Wins the Client Choice Award 2019 by Lexology

    Bär & Karrer is pleased to announce that partner Paolo Bottini has been recognized by Lexology and the International Law Office (ILO) as the Client Choice Winner 2019 in the Corporate Tax category in Switzerland.
  • Bär & Karrer Advises CEVA Logistics in Connection with the Strengthening of the Strategic Partnersh

    On 11 October 2018, the board of directors of CEVA Logistics AG announced that the Danish transport and logistic company DSV submitted a non-binding letter of interest with an indicative offer price of CHF 27.75 per CEVA share and that the board of directors of CEVA came to the conclusion that the offer was not in the best interest of the company and its shareholders. This was in particular because at that point in time, CEVA was already in discussions regarding an intensified cooperation with its main shareholder CMA CGM S.A., which shall exploit the full potential of CEVA.